Efficacy and safety of long-term evolocumab use among Asian subjects - A subgroup analysis of the further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk (fourier) trial -
Keech, AC, Oyama, K, Sever, PS, Tang, M, Murphy, SA, Hirayama, A, Lu, C, Tay, L, Deedwania, PC, Siu, CW, Pineda, AL, Choi, D, Charng, MJ, Amerena, John, Ahmad, WAW, Chopra, VK, Pedersen, TR, Giugliano, RP and Sabatine, MS 2021, Efficacy and safety of long-term evolocumab use among Asian subjects - A subgroup analysis of the further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk (fourier) trial -, Circulation Journal, vol. 85, no. 11, pp. 2063-2070, doi: 10.1253/circj.CJ-20-1051.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Efficacy and safety of long-term evolocumab use among Asian subjects - A subgroup analysis of the further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk (fourier) trial -
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.